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The hopes to distinguish between organic and functional dyspepsia on the
grounds of the patient's symptomatology have not been fulfilled due to the low
specificity of the so-called sinister symptoms. There is increasing evidence
accumulating that Helicobacter pylori status and other environmental factors
such as smoking have a higher discriminant power. Studies performed in our
laboratories testing H. pylori status on gastric biopsy samples have shown that
preselection of patients according to smoking habits and H. pylori status has a
higher potential in avoiding unnecessary endoscopies in primary care patients
as compared to risk factors based on patient complaints. Out of a total popula-
tion of282 primary care patients, one out of24 endoscopies revealed significant
pathology such as peptic ulcer or reflux esophagitis in the non-smokers with a
negative H. pylori status, but when both risk factors were positive, the percent-
age rose to one out of every two patients. These observation have largely been
confirmed by recent studies where H. pylori status was prospectively assessed
prior to endoscopy by highly specific H. pylori serology or 13C breath test
analysis.
INTRODUCTION
Dyspepsia is defined as any pain, discomfort or nausea referable to the upper ali-
mentary tract, which may be intermittent or continuous and has been present for at least
one month [1]. Dyspepsia is a very common clinical problem accounting for two to three
percent ofprimary care consultations and some 30 to 50 percent ofcases ofchronic upper
abdominal complaints presented to the gastroenterologist [27]. A large proportion ofthese
patients do not have recognizable organic disease and are commonly labelled as having
functional dyspepsia. Although upper gastrointestinal endoscopy is the investigation of
choice for the distinction between organic and functional dyspepsia, one must take into
account that the percentage ofrelevant organic disease found by this invasive technique is
in the range of25 to 15 percent, whereby the lower limit refers to patients ofthe primary
care setting [2-4].
The diseases most often diagnosed are peptic ulcer and reflux esophagitis; the possi-
bility ofunderlying carcinoma exists but primarily in older patients. In adequately trained
hands, ultrasonography is of special value in the search of extraintestinal organic disease,
especially gallbladder pathology, which is relatively common in dyspeptic patients.
Endoscopy is both unpleasant and costly, and many attempts have, therefore, been made in
recent years to cut down the amount of unnecessary procedures [8]. The strategies
employed are mainly based on screening for so-called clinical risk factors, also referred to
as sinister symptoms, but their discriminant power is limited due to the overall low speci-
ficity ofeachindividual factor, anditis generally recognizedthatno single symptom allows
anunequivocal diagnosis by itself[9]. Simultaneous evaluation ofspecified symptoms with
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linear discriminant analysis as well as stepwise logistic regression analysis, however,
appears to have the potential to distinguish between functional and organic dyspepsia in
approximately 70 percent ofthe cases [4, 5]. The low prevalence oforganic disease in dys-
peptic patients generally results in low positive and high negative predictive values.
Consequently, the main impact of the predictive models may be to reduce the number of
negative endoscopies rather than to predict a precise diagnosis [5]. In a dyspepsia study
aimed at establishing the clinical characteristics and prevalences of upper gastrointestinal
lesions in a large, primary-care referral, Swiss multicenter study [7], a simplified question-
naire on "risk symptoms and factors" (adapted from that proposed by Talley et al. [5]) ade-
quately identified as "patients at risk" almost two-thirds ofthe patients with peptic lesions,
while reducing the endoscopic workload to about one-third of the patients. Although the
clinical criteria used, therefore, had some discriminant power between organic and func-
tional dyspepsia, up to one-third of clinically relevant findings may have been missed. In
recent years, particular attention has been given to age, gender and environmental factors
such as smoking, drug consumption and especially Helicobacter pylori infection as risk
factors for organic dyspepsia.
GENETIC AND ACQUIRED RISK FACTORS
Role ofage as riskfactor
There is circumstantial evidence available from many epidemiological studies that
age above 45 is a risk factorforpeptic ulcerand gastric malignancy and, to a lesserdegree,
also for reflux esophagitis [5]. For the latter disease, this particularly applies to the sever-
ity ofthe condition. Gastric malignancy is particularly rare below the age of45 [10].
Role ofgender
Organic dyspepsia appears to be more common in male subjects. This relates partic-
ularly to duodenal ulcer and reflux esophagitis, but not to gastric ulcer, where a higher
NSAID consumption is likely responsible for the increased prevalence in the elderly
female population [10-12].
Role oftobacco smoking
Smoking is a well-established risk factor in duodenal ulcer disease [13-18], even
though this has long been disputed [19]. The epidemiologic evidence in favor of an
increased risk is weaker in reflux esophagitis [20] and is mostly based on observations on
the deleterious effects smoking exerts on the esophageal motility, such as a decrease in
LESP [13, 21, 22], an impairment of esophageal clearance and promotion of duo-
denogastric reflux [23, 24].
Similarly smoking is an established risk factor for esophageal carcinoma, including
adenocarcinoma in Barrett esophagus [25] and probably also for gastric carcinoma.
Role ofH. pylori
There is a strong and uncontested association of H. pylori infection and peptic ulcer
especially duodenal ulcer and to a lesser degree gastric ulcer [26, 27]. Similarly, H. pylori
infection contributes to development ofgastric cancer [28]. Nevertheless, more than 80per-
cent ofpatients infected with H. pylori never develop a peptic ulcer nor a gastric carcino-
ma, and this considerably reduces the discriminant power of H. pylori infection as a risk
factor for organic dyspepsia. There is very little evidence suggesting any direct link
between H. pylori infection and reflux esophagitis [10, 29]. Many patients with functional
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Figure 1. The sequence ofgenetic susceptibility combining with environmental factors to pro-
duce duodenal ulcer disease. (From [26] with permission.)
dyspepsia are infected with H. pylori, but the prevalence ofthis infective agent is only mar-
ginally higher than in healthy controls [30].
H. pylori induces chronic gastritis in all subjects infested, but additional genetic and
acquired risk factors, especially smoking, have long been postulated to play a facilitating
role in the promotion oforganic disease, especially peptic ulcer disease [26] (Figure 1).
DISCRIMINANT VALUE OF GENETIC AND ACQUIRED RISK FACTORS FOR
THE DISTINCTION BETWEEN ORGANIC AND FUNCTIONAL DYSPEPSIA
There are only limited data from the literature available to show to what degree the
above discussed risk factors can be considered as guidelines in helping the primary care
physician topreselectpatients atriskfororganic dyspepsia [10, 31] with areasonable con-
fidence, and thus to help reduce unnecessary endoscopies. Since there is a considerable
overlap for each factor between patients suffering from organic and functional dyspepsia,
it is ofparticular interest to evaluate the additive discriminant powerofmore than one risk
factor. It is the aim of this review paper to discuss the results of a study of our group,
where these parameters were analyzed retrospectively [32], and to compare them with the
few published prospectively sampled data.
Studies on combined risk ofH. pylori and smoking
Two hundred and eighty-two patients referred from their primary care physician were
enrolled into ourdyspepsia study [7] ifthey met the following criteria: symptoms for a min-
imum of one month, informed consent for drug trial, including upper gastrointestinal
endoscopy and H. pylori status (based on CLO-urease test on three biopsy samples). All
were prospectively screened forcriteria suggesting an organic origin ofthe disorder such as
nocturnal pain, severe pain, severe regurgitation or heartburn, loss ofweight, pain relieved
by food, age ofmore than 50 years, H. pylori status and nicotine abuse. Nonparametric data
were given as absolute numbers or percentages. Comparisons were made with the chi-
square method (with Yates correction where necessary) and the chi-squared test for trend
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All peptic lesions: Comparison between mean Prevalence
and the four Subgroups
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Figure 2. Prevalence ofall lesions (reflux oesophagitis and/or peptic ulcers) in each subgroup
(odds ratios calculated for both sexes pooled, each category vs. all others pooled). Intersection
with Y axis = non-significant difference.
(for categories in natural order). Rate differences and odds ratios as a measure of relative
risks were calculated by using the Mantel-Haentzel-Peto method.
Ofthe patients, 112/282 (39.5 percent) were H.pyloripositive. Overall, 16 percent of
patients had one or more relevant lesions: 7.8 percent esophagitis, 8.5 percent duodenal
ulcers and 1.8 percent gastric ulcers. None ofthe above mentioned clinical criteria had an
unequivocal discriminant power. However, three other factors appeared to be related to a
higher prevalence of lesions in this population of dyspeptic patients. In decreasing order
of discriminant power they were: a positive CLO-urease test (indicating H. pylori infec-
tion), smoking and male gender.
Consequently, the population-both genders individually and pooled-was stratified
into four subgroups:
1. Patients who did not smoke and had a negative CLO-urease test (CLO-
Nik-).
2. Patients who did smoke and had a negative CLO-urease test (CLO-
Nik+).
3. Patients who did not smoke and had a positive CLO-urease test
(CLO+Nik-).
4. Patients who did smoke and had a positive CLO-urease test
(CLO+Nik+).
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Figure 3. Prevalence ofduodenal ulcer in eachsubgroup (odds ratios calculated for both sexes
pooled, each category vs. all others pooled). Intersection withY axis = non-significant difference.
Patients with both apositive CLO-urease test and who smoked accounted foronly 16
percent of the population but for 46 percent of the lesions, but lesions were seen in only
four percent of the 42 percent of the subjects who were non-smokers and had a negative
CLO-urease test.
The odds ratios representing the discriminant power ofthese acquired factors arepre-
sented in Figures 2 and 3
Overall, and in particular for the duodenal ulcer subgroup, a negative H. pylori sta-
tus in combination with non-smoking represented a highly significant negative discrimi-
nant factor for organic disease (odds ratio: 0.22 [0.07-0.67, 95 percent confidence inter-
val], p < .001, and 0.13 [0.02-.93, 95 percent conerdence interval], p < .001, respective-
ly), while the reverse situation, namely a positive CLO test and smoking were reflected
by a highly significant positive risk factor for organic disease (odds ratio: 4.35 [1.84-
10.29, 95 percent confidence intervals], p < .001, and 5.53 [1.97-15.53, 95 percent con-
fidence intervals], p < .001). Similarly, male sex had ahigh discriminant powerfororgan-
ic disease in the whole group (odds ratio: 3.56 [1.81-6.98, 95 percent confidence inter-
vals], p < 0.001), as well as in the duodenal ulcer subgroup (odds ratio: 2.65 [1.12-6.28,
95 percent confidence intervals] , p < .05).
In reflux esophagitis (data not shown), H. pylori status and smoking had aweakerdis-
criminant power as compared to male sex. In all four groups, males had a higher preva-
lence for the latter disease (odds ratio corrected for smoking and H. pylori status: 4.54
[1.8-9.5, 95 percent, confidence intervals], p < .001) The CLO-Nik- group had a signifi-
cantly lower probability ofhaving an esophagitis (odds ratio: 0.46 [0.13-1.63, 95 percent
confidence intervals], p < .05). Inversely, patients with a positive CLO-urease test and/or
smoking taken as a group had a significantly higher probability ofhaving an esophagitis
than the H. pylori-negative non-smokers (combined odds ratio: 2.58 [1.01-7.27, 95 per-
cent confidence intervals], p < .05).
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Figure 4. Stepwise chi-square test by highest value at each step. Data for all endoscopically
found relevant lesions. CLO-test indicates urease test for H. pylori infection. All X2 values repre-
sent a factor with significant discriminant power within the stepwise chi-square test. F = female, M
= male,Y = yes, N = no. Datagiven in percent indicate the percentage ofthe total number ofpatients
included in the study (n = 282).
The data were further analyzed by sequential chi-square test (an analysis that allows
weighing the independent contribution of each factor analogous to a stepwise regression
analysis) in which each of the putative risk factors is tested and the population stratified
for the most highly significant parameter. Each subpopulation is retested for the remain-
ing risk factors, until no significant differences remain (Figures 4 and 5). The most impor-
tant risk factor for all lesions taken together and in particular for duodenal ulcer disease
tested separately was apositive CLO test, followed by smoking. Male gender followed by
smoking were the two dominant risk factors in the CLO- ulcer group and similarly in
patients with reflux esophagitis. H. pylori infection only marginally qualified as arisk fac-
tor in patients with reflux esophagitis, particularly in female patients (p < .1).
Analysis ofthe data in view ofendoscopic yield revealed that 1:24 endoscopies were
positive in the CLO-Nik-group, 1:6 if the patients had either a positive CLO-test or were
smokers, and 1:2 in patients who were in the CLO+Nik+ group. Regarded separately, the
corresponding positive yields were 1:30, 1:10 and 1:7 for reflux esophagitis and 1:119
(CLO-Nik-), 1:26 (smokers), 1:13 (CLO+) and 1:3 (CLO+Nik+) for duodenal ulcers.
Gender, positive H. pylori status and smoking, thus, had an important and additive
discriminant value to distinguish between organic and functional dyspepsia. The results
strongly suggest that preselection of patients according to smoking habits and H. pylori
status is more helpful in avoiding unnecessary endoscopies in primary care patients as
compared to clinical risk factors based onpatient complaints. Since this statement is based
on a retrospective analysis, and since H. pylori status was assessed at endoscopy, this
observation needs to be further verified by prospective studies with the use ofahighly sen-
sitive non-invasive method for H. pylori screening, ideally with the help of the 13C-urea
breath test or one of the new highly specific serological tests. A prospective study partly
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Duodenal Ulcer
Reflux esophagitis
Figure 5. Data analyzed with the sameanalysis as inFigure 4forpatients with duodenal ulcers
(5a, top) and patients with reflux esophagitis (5b, bottom).
fulfilling these requirements has recently been published [31]. Earlier data are also avail-
able from prospective studies where H. pylori status was assessed by serology [10]. The
latter study revealed that, a positive H. pylori serology fulfills together with a history of
sinister symptoms the criteria of an independent risk factor, helping considerably to cut
down on unnecessary endoscopies.
In the study where H. pylori status was prospectively assessed with the 13C urea
breath test, 327 patients were referred for endoscopy [31]. Organic dyspepsia was found
in 52 percent ofthose with apositive result. By contrast, less than 79 percentofthose with
a negative breath test had no abnormality at endoscopy. The stepwise logistic regression
analysis identified smoking, previous upper gastrointestinal investigation and duration of
symptoms as significant independent predictors ofulcer disease in the H. pylori positive
subjects. The peptic ulcers prevalence was found to be almost two-fold as frequent in H.
pylori-positive smokers as compared to H. pylori-negative smokers. Unfortunately, the
data of that study are not fully comparable with those of our study. Their study was not
performed on primary care patients, and the rate of relevant organic dyspepsia was con-
siderably higher. Moreover, the H. pylori prevalence in their population was much high-
er (65 percent vs. 39 percent in our study), and the prevalence ofpeptic ulcers was even
more unbalanced (32 percent vs. 10.3 percent in our study). No attention was given to the
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question of whether reflux esophagitis is more frequent in H. pylori-infected smokers.
Nevertheless, the data collected in a selective group confirm ourfindings collected among
primary care patients that smoking is a prominent facilitator of organic dyspepsia in H.
pylori positive subjects, particularly for duodenal ulcer disease.
The additive risk smoking plays in H. pylori-positive subjects in developing a peptic
ulcer is indirectly confirmed by the observation ofanAustralian group that smoking is no
longer a risk factor for ulcer recurrence once H. pylori is eradicated [33].
POSSIBLE REASON FOR INCREASED RISK OF SMOKING
IN H. PYLORI POSITIVE SUBJECTS
It has been speculated that the excess ofpeptic ulcerdisease in cigarette smokers may
be explained by their increased susceptibility to H. pylori infection [33]. It is more likely
that the mucosa of H. pylori-infected subjects is more susceptible to smoking-induced
damage, e.g., by reducing blood flow as suggested by Taha et al. [35].
CONCLUSION
There is increasing evidence that smoking represents a very substantial additive risk
for development of organic dyspepsia in H. pylori-positive subjects. This relates particu-
larly to peptic ulcer disease, whereas its relation to reflux esophagitis needs further inves-
tigation. Similarly, male gender and advanced age are accompanied by a higher risk for
organic dyspepsia. Clearly, absence of any of these risk factors does not fully exclude
organic disease, but the likelihood offinding relevant pathology in young H. pylori-nega-
tive subjects who are non-smokers is an important argument against an early endoscopy
in this group. Here, endoscopy should be reserved to those patients who do notrespond to
a simple probatory therapy within one to two months.
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